MET and cancer: The binding of HGF to c-Met’s Sema domain results in receptor homodimerization, autophosphorylation of tyrosine residues in the tyrosine kinase domain, and downstream activation of some signaling pathways, which contribute to the malignant transformation of a wide range of cancers (17, 18).